SCRIPTGEN

Scriptgen Pharmaceuticals, Inc.

Application Filed: 1995-05-08

Trademark Application Details

Status

606

Dead/Abandoned

ABANDONED - NO STATEMENT OF USE FILED

Research	OneLook Acronym Finder
Serial Number	74670649
Mark Drawing Code	3S09: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Attorney Name	S. Peter Ludwig
Attorney Docket Number	0342.3B429
Law Office Assigned	L50
Employee Name	SMITH, LAURA

Timeline

1995-05-08	Application Filed
1996-08-27	Published for Opposition
1999-11-20	Abandon
1999-11-20	Status: Dead/Abandoned
2000-02-11	Location: FILE REPOSITORY (FRANCONIA)
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	SCRIPTGEN PHARMACEUTICALS, INC.
Address	200 Boston Avenue - Suite 3000 Medford DE 02155
Legal Entity Type	Corporation
Legal Entity State	DE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Design Search Codes

260120	Circles within a circle
260126	Coils; Spirals; Swirls

Attorney of Record

S. Peter Ludwig
Darby & Darby P.C.
805 Third Avenue
New York, NY 10022

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052
International Codes:	42
U.S. Codes:	100,101

Type Code	Type
GS0051	pharmaceutical preparations for the treatment of infectious diseases including, but not limited to bacterial, fungal, and viral infections; peripheral or central nervous system diseases including, but not limited to schizophrenia, depression, alzheimers, migraines, anxiety, and pain; cardiovascular system diseases including, but not limited to atherosclerosis, hypertension, stroke, and congestive heart failure; digestive organs diseases including, but not limited to gastric ulcers, and esophagal reflux; musculosketal system diseases including, but not limited to arthritis; metabolic diseases including, but not limited to obesity and diabetes; respiratory system diseases including, but not limited to asthma, pneumonia, and tuberculosis; urogenital organs diseases including, but not limited to cystitis, yeast infections, and hepatitis; neoplastic diseases including, but not limited to cancer of the breast, lung, prostate, and colon; skin disorders including, but not limited to psoriasis and herpes; immune system diseases including, but not limited to HIV, rheumatoid arthritis, and immune suppression agents for organ transplants; hematopoietic diseases including, but not limited to sickle cell anemia, thalassemia, hemostasis and other blood disorders; genetic diseases including, but not limited to down's syndrome, huntington's chorea, and cystic fibrosis; endocrine system diseases including, but not limited to symptoms of menopause; reproductive system diseases including, but not limited to fertility control

Type Code

Type

GS0051

pharmaceutical preparations for the treatment of infectious diseases including, but not limited to bacterial, fungal, and viral infections; peripheral or central nervous system diseases including, but not limited to schizophrenia, depression, alzheimers, migraines, anxiety, and pain; cardiovascular system diseases including, but not limited to atherosclerosis, hypertension, stroke, and congestive heart failure; digestive organs diseases including, but not limited to gastric ulcers, and esophagal reflux; musculosketal system diseases including, but not limited to arthritis; metabolic diseases including, but not limited to obesity and diabetes; respiratory system diseases including, but not limited to asthma, pneumonia, and tuberculosis; urogenital organs diseases including, but not limited to cystitis, yeast infections, and hepatitis; neoplastic diseases including, but not limited to cancer of the breast, lung, prostate, and colon; skin disorders including, but not limited to psoriasis and herpes; immune system diseases including, but not limited to HIV, rheumatoid arthritis, and immune suppression agents for organ transplants; hematopoietic diseases including, but not limited to sickle cell anemia, thalassemia, hemostasis and other blood disorders; genetic diseases including, but not limited to down's syndrome, huntington's chorea, and cystic fibrosis; endocrine system diseases including, but not limited to symptoms of menopause; reproductive system diseases including, but not limited to fertility control

Trademark Filing History

Description	Date	Event Coding
ASSIGNED TO EXAMINER	1995-09-20	1 DOCK D:Assigned to Examiner
ASSIGNED TO EXAMINER	1995-09-21	2 DOCK D:Assigned to Examiner
NON-FINAL ACTION MAILED	1995-09-29	3 CNRT F:First Action
CORRESPONDENCE RECEIVED IN LAW OFFICE	1996-03-26	4 CRFA I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER	1996-06-13	5 CNSA P:
NOTICE OF PUBLICATION	1996-07-26	6 NPUB O:Outgoing Correspondence
PUBLISHED FOR OPPOSITION	1996-08-27	7 PUBO A:Allowance for Publication
NOA MAILED - SOU REQUIRED FROM APPLICANT	1996-11-19	8 NOAM O:Outgoing Correspondence
EXTENSION 1 FILED	1997-02-26	9 EXT1 S:
EXTENSION 1 GRANTED	1997-04-03	10 EX1G S:
EXTENSION 2 FILED	1997-11-12	11 EXT2 S:
EXTENSION 2 GRANTED	1997-12-18	12 EX2G S:
EXTENSION 3 FILED	1998-03-03	13 EXT3 S:
EXTENSION 3 GRANTED	1998-04-13	14 EX3G S:
EXTENSION 4 FILED	1998-09-03	15 EXT4 S:
EXTENSION 4 GRANTED	1998-09-22	16 EX4G S:
EXTENSION 5 FILED	1999-02-16	17 EXT5 S:
EXTENSION 5 GRANTED	1999-03-08	18 EX5G S:
ABANDONMENT - NO USE STATEMENT FILED	2000-02-07	19 ABN6 S:

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
SCRIPTGEN 97741519 not registered Live/Pending	Kelman, Evan 2023-01-04
SCRIPTGEN 75810719 not registered Dead/Abandoned	SCRIPTGEN PHARMACEUTICALS, INC. 1999-09-29
SCRIPTGEN 74670649 not registered Dead/Abandoned	SCRIPTGEN PHARMACEUTICALS, INC. 1995-05-08
SCRIPTGEN 74599005 not registered Dead/Abandoned	SCRIPTGEN PHARMACEUTICALS, INC. 1994-11-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.